Are you interested in exploring collaboration possibilities?
Enter your information in the form and a representative will contact you shortly.
Type III and VI Collagen Have the Potential to Distinguish Between IPF and HP
May 17, 2025
Type III and VI Collagen remodeling biomarkers have the potential to distinguish between IPF and HP
Introduction
IPF and HP are two ILDs with similar clinical phenotype but distinct management, making their precise separation critical. Serological biomarkers may assist in distinguishing the two. In this study we assessed the clinical value of type III and VI collagen remodeling biomarkers and their potential to act as a tool to distinguish between HP and IPF in two separate, independent cohorts.
Poster
Conclusion
We conclude that nordicPRO-C3™ could distinguish between HP and IPF in the AUH-ILD cohort. Furthermore, the distinct collagen remodeling takes place in each disease. In conclusion, these findings suggest that ECM remodeling biomarkers could act as potential tools to distinguish between HP and IPF.
